- AMG-3
Drugbox
IUPAC_name = (6aR,10aR)-3-(2-hexyl-1,3-dithiolan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo [c] chromen-1-ol
width= 240
CAS_number=
ATC_prefix=
ATC_suffix=
PubChem= 10002952
DrugBank=
C=25 | H=36 | O=2 | S=2
molecular_weight = 432.681 g/mol
smiles = CCCCCCC4(SCCS4)c(cc1O)cc(OC(C)(C)C2CC=3)c1C2CC=3C
bioavailability=
metabolism =
elimination_half-life=
excretion =
pregnancy_category =
legal_status =
routes_of_administration=AMG-3 is an
analgesic drug which is acannabinoid agonist . It is a derivative of Δ8THC substituted with adithiolane group on the 3-position side chain. [Mavromoustakos T, Theodoropoulou E, Zervou M, Kourouli T, Papahatjis D. Structure elucidation and conformational properties of synthetic cannabinoids (-)-2-(6a,7,10,10a-tetrahydro-6,6,9-trimethyl-1-hydroxy-6H-dibenzo [b,d] pyranyl)-2-hexyl-1,3-dithiolane and its methylated analog. "Journal of Pharmaceutical and Biomedical Analysis". 1999 Jan;18(6):947-56. PMID 9925329] AMG-3 is a potent agonist at both CB1 and CB2 receptors with a Ki of 0.32nM at CB1 and 0.52nM at CB2, [Papahatjis DP, Kourouli T, Abadji V, Goutopoulos A, Makriyannis A. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols. "Journal of Medicinal Chemistry". 1998 Mar 26;41(7):1195-200. PMID 9544219] [Papahatjis DP, Nikas SP, Kourouli T, Chari R, Xu W, Pertwee RG, Makriyannis A. Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'. "Journal of Medicinal Chemistry". 2003 Jul 17;46(15):3221-9. PMID 12852753] and its particularly high binding affinity has led to it being used as a template for further structural development of novel cannabinoid drugs. [Durdagi S, Papadopoulos MG, Papahatjis DP, Mavromoustakos T. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity. "Bioorganic and Medicinal Chemistry Letters". 2007 Dec 15;17(24):6754-63. PMID 17980589] It hassedative and analgesic effects, with analgesia lasting for up to 24 hours after administration. [Antoniou K, Galanopoulos A, Vlachou S, Kourouli T, Nahmias V, Thermos K, Panagis G, Daifoti Z, Marselos M, Papahatjis D, Spyraki C. Behavioral pharmacological properties of a novel cannabinoid 1',1'-dithiolane delta8-THC analog, AMG-3. "Behavioural Pharmacology". 2005 Sep;16(5-6):499-510. PMID 16148456]References
Wikimedia Foundation. 2010.